Wang, Chengdi
Liu, Wen-Rong
Tan, Shuangyan
Zhou, Jian-Kang
Xu, Xiaomin
Ming, Yue
Cheng, Jian
Li, Jiao
Zeng, Zhen
Zuo, Yuanli
He, Juan
Peng, Yong https://orcid.org/0000-0002-1181-3467
Li, Weimin
Funding for this research was provided by:
National Key R&D Program of China (2017YFA0504304)
National Natural Science Foundation of China (91859203, 81871890, 92159302)
Article History
Received: 14 January 2022
Accepted: 21 February 2022
First Online: 2 March 2022
Declarations
:
: The study was approved by the Ethics Committee of West China Hospital of Sichuan University. All patients provided written informed consent for genomic analysis of their cancer as well as participation in the study.
: The authors approved the publication of this manuscript.
: The authors declare that they have no competing interests.